| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.33 | 4e-10 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |